Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

Provided By GlobeNewswire

Last update: Mar 27, 2025

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2024 and provided a corporate update.